The human prostatic carcinoma cell line LNCaP and its derivatives G. J. van SteenbruggeM. GroenJ. Horoszewicz Review Pages: 71 - 77
Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP J. J. KönigE. KamstF. H. Schröder Original Articles Pages: 79 - 86
Structure and function of the androgen receptor A. O. BrinkmannP. KlaasenJ. Trapman Original Articles Pages: 87 - 93
Androgens during different modes of endocrine treatment of prostatic cancer Å. PousetteK. CarlströmR. Stege Original Articles Pages: 95 - 98
Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy O. G. J. M. van AubelJ. Bolt-de VriesF. H. Schröder Original Articles Pages: 99 - 102
Difference in uptake of 3H-estramustine in two human prostatic carcinoma cell lines, LNCaP and LNCaP-r M. Hasenson Original Articles Pages: 103 - 106
Investigations of trace elements in metastases and primary carcinoma of the prostate A. FeustelR. WennrichH. Dittrich Original Articles Pages: 107 - 109
Antiproliferative effect of interferons on human prostate carcinoma cell lines G. SicaL. FabbroniM. Pavone-Macaluso Original Articles Pages: 111 - 115
Study on pathogenesis of Enterococcus faecalis in urinary tract T. HiroseY. KumamotoT. Tsukamoto Original Articles Pages: 125 - 129
Effects of photochemical donor pretreatment on the pattern of dog renal allograft infiltrating cells J. KadenH. OesterwitzR. Schirrow Original Articles Pages: 131 - 134
Age factor in post-nephrectomy compensatory renal growth E. -X. LuC. -P. WuF. -L. Gu Original Articles Pages: 135 - 139
